Do we have any anecdotal information?I stepped away from paying much attention for some time while taking care of my father, who had Stage IV Neuroendocrine Rectal Cancer. Dad passed away on May 29th, after around a 1 year fight this second time having the same form of rectal cancer. I'm getting back to my more normal routines, but still playing major catch up.
Based on the board activity. It looks like everyone has pretty much lost interest and are simply waiting on oncology results and/or for profit to grow by streamlining the company going forward. I cannot believe Paul is even contemplating an acquisition at this point, but I'm assuming that's just another selling tactic and attempt at giving investors something to look forward too. I actually like what the company has been able to accomplish, but I am a little worried about those sales projections. They've never been honest about anything in the past.
Does anyone have any anecdotal information on the oncology platform? That's the only reason why I'm here, and it still feels like a complete lottery ticket at this point.